Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. (Q35000243)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. |
scientific article |
Statements
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase (English)
Gordon B Mills
Joe W Gray
Laura M Heiser
Xiaoyong Fu
Chad J Creighton
Nrusingh C Biswal
Vijetha Kumar
Martin Shea
Sabrina Herrera
Alejandro Contreras
Carolina Gutierrez
Tao Wang
Sarmistha Nanda
Mario Giuliano
Gladys Morrison
Kristen L Karlin
Thomas F Westbrook
Pavana Anur
Sylvie M Guichard
Paul D Smith
Barry R Davies
Teresa Klinowska
Adrian V Lee
Mothaffar F Rimawi
Susan G Hilsenbeck
C Kent Osborne
Rachel Schiff
11 September 2014
11 September 2014
1 reference
1 reference
1 reference
1 reference